您使用提示模式 关闭
为了方块之间的快速移动

组织机构: Allergan Sales
LEI 254900TUPGX2F5Y3AU71

机构名称
Allergan Sales, LLC
国家名称
美国
注册登记国
美国
行业
药品生产和生物技术
债券负债
-

探索最全面的数据库

80 万

债券

超过 400

定价来源

8 万

股票

9 千

ETF

以最有效的方式跟踪您的投资组合
债券筛选器
观察列表
Excel 附加组件

最新数据在

卖价

查询已发送
无法访问
信息提供者所提供的报价仅供参考。

简介

Allergan Sales, LLC (f.n.a.Forest Laboratories, Inc. (Forest)) develops, manufactures and sells branded forms of ethical drug products, which requires a physician's prescription. The Company focuses on the development and introduction of new products, including products developed in collaboration with licensing partners. The Company’s products include Namenda, the Company's NMDA antagonist for the treatment of moderate to severe dementia of the Alzheimer's type; Bystolic is a beta-blocker for the treatment of hypertension; Linzess is a guanylate cyclase type-C receptor agonist for the once-daily treatment for men and women suffering from IBS-C or CIC; Tudorza is a long-acting antimuscarinic agent for the long-term maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema, and Viibryd is an SSRI and a 5-HT1A receptor partial agonist for the treatment of adults with major depressive disorder (MDD).

奖项

相关文件

股票

最近一次的发行

债券负债 (按货币)

代码

  • LEI
    254900TUPGX2F5Y3AU71
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • ICB
    4.500 Health Care

信用和 ESG 评级

宏观经济指数

你必须 注册 才能获得访问权